Lessons in signaling and tumorigenesis from polyomavirus middle T antigen

Microbiology and Molecular Biology Reviews

Volumn 73, Issue 3, 2009, Pages 542-563

  Fluck, Michele M ^a   Schaffhausen, Brian S ^b  

^a Michigan State University ^*  (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN 70; MUTANT PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE C GAMMA1; PHOSPHOPROTEIN PHOSPHATASE 2A; PROLINE; PROTEIN 14 3 3; PROTEIN TYROSINE KINASE; TAZ PROTEIN; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS MIDDLE T ANTIGEN; VIRUS VECTOR;

BINDING AFFINITY; CELL INTERACTION; EPITHELIUM CELL; GENE EXPRESSION; GENE MUTATION; HUMAN; METASTASIS; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; POLYOMA VIRUS; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; STROMA CELL; TRANSCRIPTION INITIATION; TRANSGENICS; TUMOR GROWTH; VIRUS CARCINOGENESIS; VIRUS GENE; VIRUS INFECTION;

ANIMALS; ANTIGENS, POLYOMAVIRUS TRANSFORMING; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; MICE; MICE, TRANSGENIC; POLYOMAVIRUS; POLYOMAVIRUS INFECTIONS; SIGNAL TRANSDUCTION; TUMOR VIRUS INFECTIONS;

POLYOMAVIRUS;

EID: 70349467638     PISSN: 10922172     EISSN: None     Source Type: Journal    
DOI: 10.1128/MMBR.00009-09     Document Type: Review

References (350)

1. Aguzzi, A., E. F. Wagner, R. L. Williams, and S. A. Courtneidge. 1990. Sympathetic hyperplasia and neuroblastomas in transgenic mice expressing polyoma middle T antigen. New Biol. 2:533-543. (Pubitemid 20316419)
2. Allison, A. C., J. N. Monga, and V. Hammond. 1974. Increased susceptibility to virus oncogenesis of congenitally thymus-deprived nude mice. Nature 252:746-747.
3. Almholt, K., K. A. Green, A. Juncker-Jensen, B. S. Nielsen, L. R. Lund, and J. Romer. 2007. Extracellular proteolysis in transgenic mouse models of breast cancer. J. Mammary Gland Biol. Neoplasia 12:8383-8397 (Pubitemid 46394928)
4. Almholt, K., A. Juncker-Jensen, O. D. Laerum, K. Dano, M. Johnsen, L. R. Lund, and J. Romer. 2008. Metastasis is strongly reduced by the matrix metalloproteinase inhibitor Galardin in the MMTV-PymT transgenic breast cancer model. Mol. Cancer Ther. 7:2758-2767.
5. c-src synthesis by inducible RNA complementary to c-src mRNA in polyomavirus-transformed rat cells. Mol. Cell. Biol. 6:2305-2316.
6. Andrews, D. W., J. Gupta, and G. Abisdris. 1993. Evidence that the middle T antigen of polyomavirus interacts with the membrane skeleton. Mol. Cell. Biol. 13:4703-4713.
7. Asselin, C., C. Gelinas, and M. Bastin. 1983. Role of the three polyoma virus early proteins in tumorigenesis. Mol. Cell. Biol. 3:1451-1459.
8. Asselin, C., C. Gelinas, P. Branton, and M. Bastin. 1984. Polyoma middle T antigen requires cooperation from another gene to express the malignant phenotype in vivo. Mol. Cell. Biol. 4:755-760.
9. Atencio, I. A., F. F. Shadan, X. J. Zhou, N. D. Vaziri, and L. P. Villarreal. 1993. Adult mouse kidneys become permissive to acute polyomavirus infection and reactivate persistent infections in response to cellular damage and regeneration. J. Virol. 67:1424-1432.
10. Atencio, I. A., and L. P. Villarreal. 1994. Polyomavirus replicates in differentiating but not in proliferating tubules of adult mouse polycystic kidneys. Virology 201:26-35.
11. Ballmer-Hofer, K., and T. L. Benjamin. 1985. Phosphorylation of polyoma middle T antigen and cellular proteins in purified plasma membranes of polyoma virus-infected cells. EMBO J. 4:2321-2327.
12. Bautch, V. L. 1989. Effects of polyoma virus oncogenes in transgenic mice. Mol. Biol. Med. 6:309-317.
13. Bautch, V. L., S. Toda, J. A. Hassell, and D. Hanahan. 1987. Endothelial cell tumors develop in transgenic mice carrying polyoma virus middle T oncogene. Cell 51:529-537.
14. Benjamin, T. L. 1982. The hr-t gene of polyoma virus. Biochim. Biophys. Acta 695:69-95.
15. Benz, C. C., R. C. O'Hagan, B. Richter, G. K. Scott, C. H. Chang, X. Xiong, K. Chew, B. M. Ljung, S. Edgerton, A. Thor, and J. A. Hassell. 1997. HER2/Neu and the Ets transcription activator PEA3 are coordinately upregulated in human breast cancer. Oncogene 15:1513-1525.
16. Berebbi, M., L. Dandolo, J. Hassoun, A. M. Bernard, and D. Blangy. 1988. Specific tissue targeting of polyoma virus oncogenicity in athymic nude mice. Oncogene 2:149-156. (Pubitemid 18058998)
17. Bergers, G., P. Graninger, S. Braselmann, C. Wrighton, and M. Busslinger. 1995. Transcriptional activation of the fra-1 gene by AP-1 is mediated by regulatory sequences in the first intron. Mol. Cell. Biol. 15:3748-3758.
18. Berjanskii, M. V., M. I. Riley, A. Xie, V. Semenchenko, W. R. Folk, and S. R. Van Doren. 2000. NMR structure of the N-terminal J. domain of murine polyomavirus T antigens. Implications for DnaJ-like domains and for mutations of T antigens. J. Biol. Chem. 275:36094-36103.
19. Bierie, B., D. G. Stover, T. W. Abel, A. Chytil, A. E. Gorska, M. Aakre, E. Forrester, L. Yang, K. U. Wagner, and H. L. Moses. 2008. Transforming growth factor-beta regulates mammary carcinoma cell survival and interaction with the adjacent microenvironment. Cancer Res. 68:1809-1819.
20. Blaikie, P. A., E. Fournier, S. M. Dilworth, D. Birnbaum, J. P. Borg, and B. Margolis. 1997. The role of the Shc phosphotyrosine interaction/ phosphotyrosine binding domain and tyrosine phosphorylation sites in polyoma middle T antigen-mediated cell transformation. J. Biol. Chem. 272:20671-20677.
21. Bolen, J. B., V. Deseau, J. O'Shaughnessy, and S. Amini. 1987. Analysis of middle tumor antigen and pp60c-src interactions in polyoma virus-transformed rat cells J. Virol. 61:3299-3305.
22. Bolen, J. B., C. J. Thiele, M. A. Israel, W. Yonemoto, L. A. Lipsich, and J. S. Brugge. 1984. Enhancement of cellular src gene product associated tyrosylkinase activity following polyoma virus infection and transformation. Cell 38:767-777.
23. c-src binding to polyomavirus middle T-antigen (MT) requires residues 185 to 210 of the MT sequence. J. Virol. 71:5512-5520.
24. Bronson, R., C. Dawe, J. Carroll, and T. Benjamin. 1997. Tumor induction by a transformation-defective polyoma virus mutant blocked in signaling through shc. Proc. Natl. Acad. Sci. USA 94:7954-7958.
25. Bustelo, X. R., V. Sauzeau, and I. M. Berenjeno. 2007. GTP-binding proteins of the Rho/Rac family: regulation, effectors and functions in vivo. Bioessays 29:356-370.
26. Campbell, K. S., K. R. Auger, B. A. Hemmings, T. M. Roberts, and D. C. Pallas. 1995. Identification of regions in polyomavirus middle T and small t antigens important for association with protein phosphatase 2A. J. Virol. 69:3721-3728.
27. Campbell, K. S., K. P. Mullane, I. A. Aksoy, H. Stubdal, J. Zalvide, J. M. Pipas, P. A. Silver, T. M. Roberts, B. S. Schaffhausen, and J. A. DeCaprio. 1997. DnaJ/hsp40 chaperone domain of SV40 large T antigen promotes efficient viral DNA replication. Genes Dev. 11:1098-1110.
28. Campbell, K. S., E. Ogris, B. Burke, W. Su, K. R. Auger, B. J. Druker, B. S. Schaffhausen, T. M. Roberts, and D. C. Pallas. 1994. Polyoma middle T antigen interacts with SHC via the NPTY motif in middle T. Proc. Natl. Acad. Sci. USA 91:6344-6348.
29. Cardiff, R. D., M. R. Anver, B. A. Gusterson, L. Hennighausen, R. A. Jensen, M. J. Merino, S. Rehm, J. Russo, F. A. Tavassoli, L. M. Wakefield, J. M. Ward, and J. E. Green. 2000. The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting. Oncogene 19:968-988.
30. Carmichael, G., B. Schaffhausen, D. Dorsky, D. Oliver, and T. Benjamin. 1982. The role of the carboxy terminus of middle T antigen of polyoma virus. Proc. Natl. Acad. Sci. USA 79:3579-3583.
31. Carmichael, G., B. S. Schaffhausen, G. Mandel, T. J. Liang, and T. L. Benjamin. 1984. Transformation by polyoma virus is drastically reduced by substitution of phenylalanine for tyrosine at residue 315 of middle-sized tumor antigen. Proc. Natl. Acad. Sci. USA 81:679-683.
32. Carpenter, C., B. Duckworth, K. Auger, B. Cohen, B. S. Schaffhausen, and L. C. Cantley. 1990. Purification and characterization of phosphoinositide 3-kinase from rat liver. J. Biol. Chem. 265:19704-19711.
33. Carpenter, C. L., K. R. Auger, M. Chanudhuri, M. Yoakim, B. Schaffhausen, S. Shoelson, and L. C. Cantley. 1993. Phosphoinositide 3-kinase is activated by phosphopeptides that bind to the SH2 domains of the 85-kDa subunit. J. Biol. Chem. 268:9478-9483.
34. Cartwright, C. A., W. Eckhart, S. Simon, and P. L. Kaplan. 1987. Cell transformation by pp60c-src mutated in the carboxy-terminal regulatory domain. Cell 49:8383-8391
35. c-src associated with polyoma middle tumor antigen. Mol. Cell. Biol. 6:1562-1570.
36. Casalino, L., D. De Cesare, and P. Verde. 2003. Accumulation of Fra-1 in ras-transformed cells depends on both transcriptional autoregulation and MEK-dependent posttranslational stabilization. Mol. Cell. Biol. 23:4401-4415.
37. Cayla, X., K. Ballmer-Hofer, W. Merlevede, and J. Goris. 1993. Phosphatase 2A associated with polyomavirus small-T or middle-T antigen is an okadaic acid-sensitive tyrosyl phosphatase. Eur. J. Biochem. 214:281-286.
38. Cecena, G., F. Wen, R. D. Cardiff, and R. G. Oshima. 2006. Differential sensitivity of mouse epithelial tissues to the polyomavirus middle T oncogene. Am. J. Pathol. 168:310-320.
39. Chan, S. W., C. J. Lim, K. Guo, C. P. Ng, I. Lee, W. Hunziker, Q. Zeng, and W. Hong. 2008. A role for TAZ in migration, invasion, and tumorigenesis of breast cancer cells. Cancer Res. 68:2592-2598. (Pubitemid 351556257)
40. Chang, H. W., M. Aoki, D. Fruman, K. R. Auger, A. Bellacosa, P. N. Tsichlis, L. C. Cantley, T. M. Roberts, and P. K. Vogt. 1997. Transformation of chicken cells by the gene encoding the catalytic subunit of PI 3-kinase. Science 276:1848-1850. (Pubitemid 27443659)
41. Chen, L., and M. M. Fluck. 2001. Role of middle T-small T in the lytic cycle of polyomavirus: control of the early-to-late transcriptional switch and viral DNA replication. J. Virol. 75:8380-8389. (Pubitemid 32768942)
42. Chen, L., X. Wang, and M. M. Fluck. 2006. Independent contributions of polyomavirus middle T and small T to the regulation of early and late gene expression and DNA replication. J. Virol. 80:7295-7307. (Pubitemid 44092552)
43. Chen, M., D. Redenius, F. Osati-Ashtiani, and M. Fluck. 1995. Enhancermediated role for polyomavirus middle T/small T in DNA replication. J. Virol. 69:326-333. (Pubitemid 24378809)
44. Chen, W., J. D. Arroyo, J. C. Timmons, R. Possemato, and W. C. Hahn. 2005. Cancer-associated PP2A Aα subunits induce functional haploinsuffi- ciency and tumorigenicity. Cancer Res. 65:8183-8192. (Pubitemid 41330582)
45. Chen, W., R. Possemato, K. T. Campbell, C. A. Plattner, D. C. Pallas, and W. C. Hahn. 2004. Identification of specific PP2A complexes involved in human cell transformation. Cancer Cell 5:127-136. (Pubitemid 38283799)
46. Chen, Y., R. Freund, M. Listerud, Z. Wang, and D. A. Talmage. 1999. Retinoic acid inhibits transformation by preventing phosphatidylinositol 3-kinase dependent activation of the c-fos promoter. Oncogene 18:139-148. (Pubitemid 29060587)
47. Chen, Y., Y. Xu, Q. Bao, Y. Xing, Z. Li, Z. Lin, J. B. Stock, P. D. Jeffrey, and Y. Shi. 2007. Structural and biochemical insights into the regulation of protein phosphatase 2A by small t antigen of SV40. Nat. Struct. Mol. Biol. 14:527-534.
48. Cheng, A. M., T. M. Saxton, R. Sakai, S. Kulkarni, G. Mbamalu, W. Vogel, C. G. Tortorice, R. D. Cardiff, J. C. Cross, W. J. Muller, and T. Pawson. 1998. Mammalian Grb2 regulates multiple steps in embryonic development and malignant transformation. Cell 95:793-803.
49. Cheng, S. H., P. C. Espino, J. Marshall, R. Harvey, and A. E. Smith. 1990. Stoichiometry of cellular and viral components in the polyomavirus middle- T antigen-tyrosine kinase complex. Mol. Cell. Biol. 10:5569-5574.
50. Cheng, S. H., R. Harvey, P. C. Espino, K. Semba, T. Yamamoto, T. K., and A. E. Smith. 1988. Peptide antibodies to the human c-fyn gene product demonstrate pp59c-fyn is capable of complex formation with the middle-T antigen of polyomavirus. EMBO J. 7:3845-3855.
51. Cheng, S. H., W. Markland, A. F. Markham, and A. E. Smith. 1986. Mutations around the NG59 lesion indicate an active association of polyoma virus middle-T antigen with pp60c-src is required for cell transformation. EMBO J. 5:325-334.
52. Cheng, S. H., W. H. Piwnica, R. W. Harvey, T. M. Roberts, and A. E. Smith. 1988. The carboxy terminus of pp60c-src is a regulatory domain and is involved in complex formation with the middle-T antigen of polyomavirus. Mol. Cell. Biol. 8:1736-1747.
53. Cheng, Y. S., and L. B. Chen. 1981. Detection of phosphotyrosine- containing 34,000-dalton protein in the framework of cells transformed with Rous sarcoma virus. Proc. Natl. Acad. Sci. USA 78:2388-2392.
54. Cheung, A., L. Young, P. Chen, C. Chao, A. Ndoye, P. Barry, W. Muller, and R. Cardiff. 1997. Microcirculation and metastasis in a new mouse mammary tumor model system. Int. J. Oncol. 11:69-77.
55. Cho, U. S., S. Morrone, A. A. Sablina, J. D. Arroyo, W. C. Hahn, and W. Xu. 2007. Structural basis of PP2A inhibition by small t antigen. PLoS Biol. 5:e202.
56. Cohen, B., Y. X. Liu, B. Druker, T. M. Roberts, and B. S. Schaffhausen. 1990. Characterization of pp85, a target of oncogenes and growth factor receptors. Mol. Cell. Biol. 10:2909-2915.
57. Coleman, S., G. B. Silberstein, and C. W. Daniel. 1988. Ductal morphogenesis in the mouse mammary gland: evidence supporting a role for epidermal growth factor. Dev. Biol. 127:304-315.
58. Connolly, J. O., N. Soga, X. L. Guo, U. Alvarez, and K. A. Hruska. 2000. Rac is essential in the transformation of endothelial cells by polyoma middle T. Cell Adhes. Commun. 7:409-422.
59. Cook, D. N., and J. A. Hassell. 1990. The amino terminus of polyomavirus middle T antigen is required for transformation. J. Virol. 64:1879-1887.
60. Cook, D. N., N. Pavloff, and J. A. Hassell. 1990. Simultaneous overexpression of avian pp60c-src and polyomavirus middle T antigen in mammalian cells. J. Virol. 64:2392-2395. (Pubitemid 20148489)
61. Cook, S. J., N. Aziz, and M. McMahon. 1999. The repertoire of Fos and Jun proteins expressed during the G1 phase of the cell cycle is determined by the duration of mitogen-activated protein kinase activation. Mol. Cell. Biol. 19:330-341.
62. Cooper, J. A., K. L. Gould, C. A. Cartwright, and T. Hunter. 1986. Tyr527 is phosphorylated in pp60c-src: implications for regulation. Science 231:1431-1434.
63. Courtneidge, S., and A. E. Smith. 1983. Polyoma virus transforming protein associates with the product of the c-src cellular gene. Nature 303:435-439.
64. Courtneidge, S. A. 1985. Activation of the pp60c-src kinase by middle T antigen binding or by dephosphorylation. EMBO J. 4:1471-1477.
65. Courtneidge, S. A., L. Goutebroze, A. Cartwright, A. Heber, S. Scherneck, and J. Feunteun. 1991. Identification and characterization of the hamster polyomavirus middle T antigen. J. Virol. 65:3301-3308.
66. Courtneidge, S. A., and A. Heber. 1987. An 81kd protein complexed with middle T antigen and pp60c-src: a possible phosphatidylinositol kinase. Cell 50:1031-1037.
67. Cozma, D., L. Lukes, J. Rouse, T. H. Qiu, E. T. Liu, and K. W. Hunter. 2002. A bioinformatics-based strategy identifies c-Myc and Cdc25A as candidates for the Apmt mammary tumor latency modifiers. Genome Res. 12:969-975. (Pubitemid 34662290)
68. Crawford, N. P., J. Alsarraj, L. Lukes, R. C. Walker, J. S. Officewala, H. H. Yang, M. P. Lee, K. Ozato, and K. W. Hunter. 2008. Bromodomain 4 activation predicts breast cancer survival. Proc. Natl. Acad. Sci. USA 105:6380-6385.
69. Crawford, N. P., X. Qian, A. Ziogas, A. G. Papageorge, B. J. Boersma, R. C. Walker, L. Lukes, W. L. Rowe, J. Zhang, S. Ambs, D. R. Lowy, H. Anton- Culver, and K. W. Hunter. 2007. Rrp1b, a new candidate susceptibility gene for breast cancer progression and metastasis. PLoS Genet. 3:e214.
70. Crawford, N. P., A. Ziogas, D. J. Peel, J. Hess, H. Anton-Culver, and K. W. Hunter. 2006. Germline polymorphisms in SIPA1 are associated with metastasis and other indicators of poor prognosis in breast cancer. Breast Cancer Res. 8:R16.
71. Cullere, X., P. Rose, U. Thathamangalam, A. Chatterjee, K. P. Mullane, D. C. Pallas, T. L. Benjamin, T. M. Roberts, and B. S. Schaffhausen. 1998. Serine 257 phosphorylation regulates association of polyomavirus middle T antigen with 14-3-3 proteins. J. Virol. 72:558-563. (Pubitemid 28048872)
72. Dahl, J., A. Jurczak, L. Cheng, D. Baker, and T. Benjamin. 1998. Evidence of a role for phosphatidylinositol 3-kinase activation in the blocking of apoptosis by polyomavirus middle T antigen. J. Virol. 72:3221-3226. (Pubitemid 28175566)
73. Dahl, J., U. Thathamangalam, R. Freund, and T. L. Benjamin. 1992. Functional asymmetry of the regions juxtaposed to the membrane-binding sequence of polyomavirus middle T antigen. Mol. Cell. Biol. 12:5050-5058.
74. Damonte, P., J. G. Hodgson, J. Q. Chen, L. J. Young, R. D. Cardiff, and A. D. Borowsky. 2008. Mammary carcinoma behavior is programmed in the precancer stem cell. Breast Cancer Res. 10:R50.
75. Das, R., G. H. Mahabeleshwar, and G. C. Kundu. 2004. Osteopontin induces AP-1-mediated secretion of urokinase-type plasminogen activator through c-Src-dependent epidermal growth factor receptor transactivation in breast cancer cells. J. Biol. Chem. 279:11051-11064.
76. Davie, S. A., J. E. Maglione, C. K. Manner, D. Young, R. D. Cardiff, C. L. MacLeod, and L. G. Ellies. 2007. Effects of FVB/NJ and C57Bl/6J strain backgrounds on mammary tumor phenotype in inducible nitric oxide synthase deficient mice. Transgenic Res. 16:193-201.
77. Dawe, C. J. 1960. Cell sensitivity and specificity of response to polyoma virus. Natl. Cancer Inst. Monogr. 4:67-128.
78. Dawe, C. J., R. Freund, G. Mandel, K. Ballmer-Hofer, D. A. Talmage, and T. L. Benjamin. 1987. Variations in polyoma virus genotype in relation to tumor induction in mice. Characterization of wild type strains with widely differing tumor profiles. Am. J. Pathol. 127:243-261.
79. Deininger, P. L., A. Esty, P. LaPorte, H. Hsu, and T. Friedmann. 1980. The nucleotide sequence and restriction enzyme sites of the polyoma genome. Nucleic Acids Res. 8:855.
80. Delmas, V., C. Bastien, S. Scherneck, and J. Feunteun. 1985. A new member of the polyomavirus family: the hamster papovavirus. Complete nucleotide sequence and transformation properties. EMBO J. 4:1279-1286.
81. Desai, K. V., N. Xiao, W. Wang, L. Gangi, J. Greene, J. I. Powell, R. Dickson, P. Furth, K. Hunter, R. Kucherlapati, R. Simon, E. T. Liu, and J. E. Green. 2002. Initiating oncogenic event determines gene-expression patterns of human breast cancer models. Proc. Natl. Acad. Sci. USA 99:6967-6972.
82. de Villiers, J., W. Schaffner, C. Tyndall, S. Lupton, and R. Kamen. 1984. Polyoma virus DNA replication requires an enhancer. Nature 312:242-246. (Pubitemid 15201999)
83. Dey, A., J. Ellenberg, A. Farina, A. E. Coleman, T. Maruyama, S. Sciortino, J. Lippincott-Schwartz, and K. Ozato. 2000. A bromodomain protein, MCAP, associates with mitotic chromosomes and affects G2-to-M transition. Mol. Cell. Biol. 20:6537-6549.
84. Dilworth, S. M. 2002. Polyoma virus middle T antigen and its role in identifying cancer-related molecules. Nat. Rev. Cancer. 2:951-956.
85. Dilworth, S. M. 1995. Polyoma virus middle T antigen: meddler or mimic? Trends Microbiol. 3:31-35.
86. Dilworth, S. M., C. E. Brewster, M. D. Jones, L. Lanfrancone, G. Pelicci, and P. G. Pelicci. 1994. Transformation by polyoma virus middle T-antigen involves the binding and tyrosine phosphorylation of Shc. Nature 367:87-90.
87. Dilworth, S. M., H. A. Hansson, C. Darnfors, G. Bjursell, C. H. Streuli, and B. E. Griffin. 1986. Subcellular localisation of the middle and large Tantigens of polyoma. EMBO J. 5:491-499.
88. DiMaio, D., and D. Mattoon. 2001. Mechanisms of cell transformation by papillomavirus E5 proteins. Oncogene 20:7866-7873. (Pubitemid 33135313)
89. Druker, B. J., L. E. Ling, B. Cohen, T. M. Roberts, and B. S. Schaffhausen. 1990. A completely transformation-defective point mutant of polyomavirus middle T antigen which retains full associated phosphatidylinositol kinase activity. J. Virol. 64:4454-4461.
90. Druker, B. J., L. Sibert, and T. M. Roberts. 1992. Polyomavirus middle T-antigen NPTY mutants. J. Virol. 66:5770-5776.
91. Du, Z., and Y. Li. 2007. RCAS-TVA in the mammary gland: an in vivo oncogene screen and a high fidelity model for breast transformation? Cell Cycle 6:823-826.
92. Du, Z., K. Podsypanina, S. Huang, A. McGrath, M. J. Toneff, E. Bogoslovskaia, X. Zhang, R. C. Moraes, M. Fluck, D. C. Allred, M. T. Lewis, H. E. Varmus, and Y. Li. 2006. Introduction of oncogenes into mammary glands in vivo with an avian retroviral vector initiates and promotes carcinogenesis in mouse models. Proc. Natl. Acad. Sci. USA 103:17396-17401.
93. Dunant, N. M., M. Senften, and K. Ballmer-Hofer. 1996. Polyomavirus middle-T antigen associates with the kinase domain of Src-related tyrosine kinases. J. Virol. 70:1323-1330. (Pubitemid 26062889)
94. Duronio, V. 2008. The life of a cell: apoptosis regulation by the PI3K/PKB pathway. Biochem. J. 415:333-344.
95. Eckhart, W., M. A. Hutchinson, and T. Hunter. 1979. An activity phosphorylating tyrosine in polyoma T antigen immunoprecipitates. Cell 18:925. (Pubitemid 10172631)
96. Eddy, B. 1969. Polyoma virus. Virol. Monogr. 7:1-114.
97. Eichhorn, P. J., M. P. Creyghton, and R. Bernards. 2009. Protein phosphatase 2A regulatory subunits and cancer. Biochim. Biophys. Acta 1795:1-15.
98. Ellies, L. G. 2003. PyV-mT-induced parotid gland hyperplasia as detected by altered lectin reactivity is not modulated by inducible nitric oxide defi- ciency. Arch. Oral Biol. 48:415-422.
99. Elliott, J., M. D. Jones, B. E. Griffin, and N. Krauzewicz. 1998. Regulation of cytoskeletal association by a basic amino acid motif in polyoma virus middle T antigen. Oncogene 17:1797-1806. (Pubitemid 28482782)
100. El-Tanani, M. K., F. C. Campbell, V. Kurisetty, D. Jin, M. McCann, and P. S. Rudland. 2006. The regulation and role of osteopontin in malignant transformation and cancer. Cytokine Growth Factor Rev. 17:463-474. (Pubitemid 44793123)
101. Escobedo, J. A., D. R. Kaplan, W. M. Kavanaugh, C. W. Turck, and L. T. Williams. 1991. A phosphatidylinositol-3 kinase binds to platelet-derived growth factor receptors through a specific receptor sequence containing phosphotyrosine. Mol. Cell. Biol. 11:1125-1132.
102. Farina, A., M. Hattori, J. Qin, Y. Nakatani, N. Minato, and K. Ozato. 2004. Bromodomain protein Brd4 binds to GTPase-activating SPA-1, modulating its activity and subcellular localization. Mol. Cell. Biol. 24:9059-9069.
103. Fisher, G. H., S. Orsulic, E. Holland, W. P. Hively, Y. Li, B. C. Lewis, B. O. Williams, and H. E. Varmus. 1999. Development of a flexible and specific gene delivery system for production of murine tumor models. Oncogene 18:5253-5260.
104. Fluck, M. 1997. Tumor studies with polyomaviruses, p. 1926-1939. In J. R. Bertino (ed.), Encyclopedia of cancer, vol.III. Academic Press, San Diego, CA.
105. Fluck, M. M., and S. Z. Haslam. 1996. Mammary tumors induced by polyomavirus. Breast Cancer Res. Treat. 39:45-56.
106. Forrester, E., A. Chytil, B. Bierie, M. Aakre, A. E. Gorska, A. R. Sharif- Afshar, W. J. Muller, and H. L. Moses. 2005. Effect of conditional knockout of the type II TGF-beta receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis. Cancer Res. 65:2296-2302. (Pubitemid 40490139)
107. Foukas, L. C., M. Claret, W. Pearce, K. Okkenhaug, S. Meek, E. Peskett, S. Sancho, A. J. Smith, D. J. Withers, and B. Vanhaesebroeck. 2006. Critical role for the p110α phosphoinositide-3-OH kinase in growth and metabolic regulation. Nature 441:366-370. (Pubitemid 44050203)
108. Freund, R., C. J. Dawe, J. P. Carroll, and T. L. Benjamin. 1992. Changes in frequency, morphology, and behavior of tumors induced in mice by a polyoma virus mutant with a specifically altered oncogene. Am. J. Pathol. 141:1409-1425.
109. Freund, R., A. Sotnikov, R. T. Bronson, and T. L. Benjamin. 1992. Polyoma virus middle T is essential for virus replication and persistence as well as for tumor induction in mice. Virology 191:716-723. (Pubitemid 23022476)
110. Fruman, D. A., R. E. Meyers, and L. C. Cantley. 1998. Phosphoinositide kinases. Annu. Rev. Biochem. 67:481-507.
111. Galang, C. K., J. Garcia-Ramirez, P. A. Solski, J. K. Westwick, C. J. Der, N. N. Neznanov, R. G. Oshima, and C. A. Hauser. 1996. Oncogenic Neu/ ErbB-2 increases ets, AP-1, and NF- B-dependent gene expression, and inhibiting ets activation blocks Neu-mediated cellular transformation. J. Biol. Chem. 271:7992-7998.
112. Galang, C. K., W. J. Muller, G. Foos, R. G. Oshima, and C. A. Hauser. 2004. Changes in the expression of many Ets family transcription factors Chem. 279:11281-11292.
113. Garcea, R., and T. Benjamin. 1983. Host range transforming gene of polyomavirus plays a role in virus assembly. Proc. Natl. Acad. Sci. USA 80:3413-3417.
114. Garcea, R. L., D. A. Talmage, A. Harmatz, R. Freund, and T. L. Benjamin. 1989. Separation of host range from transformation functions of the hr-t gene of polyomavirus. Virology 168:312-319.
115. Garcia, R., C. L. Yu, A. Hudnall, R. Catlett, K. L. Nelson, T. Smithgall, D. J. Fujita, S. P. Ethier, and R. Jove. 1997. Constitutive activation of Stat3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells. Cell Growth Differ. 8:1267-1276. (Pubitemid 28008723)
116. Glenn, G. M., and W. Eckhart. 1995. Amino-terminal regions of polyomavirus middle T antigen are required for interactions with protein phosphatase 2A. J. Virol. 69:3729-3736.
117. c-src, and phosphatidylinositol-3 kinase, activation of c-fos expression, and cellular transformation. J. Virol. 67:1945-1952.
118. Glover, H. R., C. E. Brewster, and S. M. Dilworth. 1999. Association between src-kinases and the polyoma virus oncogene middle T-antigen requires PP2A and a specific sequence motif. Oncogene 18:4364-4370.
119. Gorga, F. R., C. E. Riney, and T. L. Benjamin. 1990. Inositol trisphosphate levels in cells expressing wild-type and mutant polyomavirus middle T antigens: evidence for activation of phospholipase C via activation of pp60csrc. J. Virol. 64:105-112.
120. Gotoh, N., A. Tojo, and M. Shibuya. 1996. A novel pathway from phosphorylation of tyrosine residues 239/240 of Shc, contributing to suppress apoptosis by IL-3. EMBO J. 15:6197-6204. (Pubitemid 26397892)
121. Gottlieb, K. A., and L. P. Villarreal. 2001. Natural biology of polyomavirus middle T antigen. Microbiol. Mol. Biol. Rev. 65:288-318.
122. Goutebroze, L., N.M. Dunant, K. Ballmer-Hofer, and J. Feunteun. 1997. The N terminus of hamster polyomavirus middle T antigen carries a determinant for specific activation of p59c-Fyn. J. Virol. 71:1436-1442. (Pubitemid 27030319)
123. Gross, L. 1953. A filterable agent, recovered from AK leukemic extracts, causing salivary gland carcinomas in C3H mice. Proc. Soc. Exp. Biol. Med. 83:414.
124. Guillermet-Guibert, J., K. Bjorklof, A. Salpekar, C. Gonella, F. Ramadani, A. Bilancio, S. Meek, A. J. Smith, K. Okkenhaug, and B. Vanhaesebroeck. 2008. The p110β isoform of phosphoinositide 3-kinase signals downstream of G protein-coupled receptors and is functionally redundant with p110gamma. Proc. Natl. Acad. Sci. USA 105:8292-8297.
125. Gunther, U., T. Mittag, and B. Schaffhausen. 2002. Probing Src homology 2 domain ligand interactions by differential line broadening. Biochemistry 41:11658-11669.
126. Guy, C. T., R. D. Cardiff, and W. J. Muller. 1992. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol. Cell. Biol. 12:954-961.
127. Guy, C. T., S. K. Muthuswamy, R. D. Cardiff, P. Soriano, and W. J. Muller. 1994. Activation of the c-Src tyrosine kinase is required for the induction of mammary tumors in transgenic mice. Genes Dev. 8:23-32.
128. Harvey, R., G. L. Oostra, G. J. Belsham, P. Gillett, and A. E. Smith. 1984. An antibody to a synthetic peptide recognizes polyoma virus middle T antigen and reveals multiple in vitro tyrosine phosphorylation sites. Mol. Cell. Biol. 4:1334-1342.
129. Haslam, S. Z., J. J. Wirth, L. J. Counterman, and M. M. Fluck. 1992. Characterization of the mammary hyperplasia, dysplasia and neoplasia induced in athymic female adult mice by polyomavirus. Oncogene 7:1295-1303.
130. Hazzalin, C. A., and L. C. Mahadevan. 2002. MAPK-regulated transcription: a continuously variable gene switch? Nat. Rev. Mol. Cell Biol. 3:30-40.
131. Heron-Milhavet, L., D. Mamaeva, A. Rochat, N. J. Lamb, and A. Fernandez. 2008. Akt2 is implicated in skeletal muscle differentiation and specifically binds prohibitin2/REA. J. Cell Physiol. 214:158-165. (Pubitemid 350220070)
132. Herschkowitz, J. I., K. Simin, V. J. Weigman, I. Mikaelian, J. Usary, Z. Hu, K. E. Rasmussen, L. P. Jones, S. Assefnia, S. Chandrasekharan, M. G. Backlund, Y. Yin, A. I. Khramtsov, R. Bastein, J. Quackenbush, R. I. Glazer, P. H. Brown, J. E. Green, L. Kopelovich, P. A. Furth, J. P. Palazzo, O. I. Olopade, P. S. Bernard, G. A. Churchill, T. Van Dyke, and C. M. Perou. 2007. Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biol. 8:R76.
133. Hiles, I. D., M. Otsu, S. Volinia, M. J. Fry, I. Gout, R. Dhand, G. Panayotou, F. Ruiz-Larrea, A. Thompson, N. Totty, J. Hsuan, S. Courtneidge, P. Parker, and M. Waterfield. 1992. Phosphatidylinositol 3-kinase: structure and expression of the 110 kd catalytic subunit. Cell 70:419-429.
134. Hodgson, J. G., T. Malek, S. Bornstein, S. Hariono, D. G. Ginzinger, W. J. Muller, and J. W. Gray. 2005. Copy number aberrations in mouse breast tumors reveal loci and genes important in tumorigenic receptor tyrosine kinase signaling. Cancer Res. 65:9695-9704.
135. Hollenhorst, P. C., A. A. Shah, C. Hopkins, and B. J. Graves. 2007. Genome-wide analyses reveal properties of redundant and specific promoter occupancy within the ETS gene family. Genes Dev. 21:1882-1894.
136. Hong, J. H., E. S. Hwang, M. T. McManus, A. Amsterdam, Y. Tian, R. Kalmukova, E. Mueller, T. Benjamin, B. M. Spiegelman, P. A. Sharp, N. Hopkins, and M. B. Yaffe. 2005. TAZ, a transcriptional modulator of mesenchymal stem cell differentiation. Science 309:1074-1078. (Pubitemid 41134465)
137. fyn with middle tumor antigen in murine polyomavirus- transformed rat cells. J. Virol. 63:2343-2347.
138. Hu, P., B. Margolis, E. Y. Skolnik, R. Lammers, A. Ullrich, and J. Schlessinger. 1992. Interaction of phosphatidylinositol 3-kinase-associated p85 with epidermal growth factor and platelet-derived growth factor receptors. Mol. Cell. Biol. 12:981-990.
139. Hu, P., A. Mondino, E. Y. Skolnik, and J. Schlessinger. 1993. Cloning of a novel, ubiquitously expressed human phosphatidylinositol 3-kinase and identification of its binding site on p85. Mol. Cell. Biol. 13:7677-7688.
140. Hunter, K. W., K. W. Broman, T. L. Voyer, L. Lukes, D. Cozma, M. T. Debies, J. Rouse, and D. R. Welch. 2001. Predisposition to efficient mammary tumor metastatic progression is linked to the breast cancer metastasis suppressor gene Brms1. Cancer Res. 61:8866-8872.
141. Hunter, T., M. A. Hutchinson, and W. Eckhart. 1984. Polyoma middle-T antigen can be phosphorylated on tyrosine at multiple sites in vitro. EMBO J. 3:73-80.
142. Hunter, T., and B. Sefton. 1980. The transforming gene product of Rous sarcoma virus phosphorylates tyrosine. Proc. Natl. Acad. Sci. USA 77:1311-1315.
143. Husemann, Y., J. B. Geigl, F. Schubert, P. Musiani, M. Meyer, E. Burghart, G. Forni, R. Eils, T. Fehm, G. Riethmuller, and C. A. Klein. 2008. Systemic spread is an early step in breast cancer. Cancer Cell 13:58-68. (Pubitemid 350309740)
144. Ichaso, N., and S. M. Dilworth. 2001. Cell transformation by the middle T-antigen of polyoma virus. Oncogene 20:7908-7916. (Pubitemid 33135317)
145. Isakoff, S. J., J. A. Engelman, H. Y. Irie, J. Luo, S. M. Brachmann, R. V. Pearline, L. C. Cantley, and J. S. Brugge. 2005. Breast cancer-associated PIK3CA mutations are oncogenic in mammary epithelial cells. Cancer Res. 65:10992-11000.
146. Ito, Y. 1979. Polyoma virus-specific 55K protein isolated from plasma membrane of productively infected cells is virus-coded and important cell transformation. Virology 98:261-266. (Pubitemid 10237465)
147. Ito, Y., J. R. Brocklehurst, and R. Dulbecco. 1977. Virus-specific proteins in the plasma membrane of cells lytically infected or transformed by polyoma virus. Proc. Natl. Acad. Sci. USA 74:4666-4670.
148. Janssens, V., and J. Goris. 2001. Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochem. J. 353:417-439. (Pubitemid 32158309)
149. Janssens, V., J. Goris, and C. Van Hoof. 2005. PP2A: the expected tumor suppressor. Curr. Opin. Genet. Dev. 15:34-41.
150. Jessen, K. A., S. Y. Liu, C. G. Tepper, J. Karrim, E. T. McGoldrick, A. Rosner, R. J. Munn, L. J. Young, A. D. Borowsky, R. D. Cardiff, and J. P. Gregg. 2004. Molecular analysis of metastasis in a polyomavirus middle T mouse model: the role of osteopontin. Breast Cancer Res. 6:R157-R169.
151. Jia, S., Z. Liu, S. Zhang, P. Liu, L. Zhang, S. H. Lee, J. Zhang, S. Signoretti, M. Loda, T. M. Roberts, and J. J. Zhao. 2008. Essential roles of PI(3)Kp110β in cell growth, metabolism and tumorigenesis. Nature 454:776-779.
152. Johnston, I. M., H. J. Spence, J. N. Winnie, L. McGarry, J. K. Vass, L. Meagher, G. Stapleton, and B. W. Ozanne. 2000. Regulation of a multigenic invasion programme by the transcription factor, AP-1: re-expression of a down-regulated gene, TSC-36, inhibits invasion. Oncogene 19:5348-5358.
153. Junttila, M. R., P. Puustinen, M. Niemela, R. Ahola, H. Arnold, T. Bottzauw, R. Ala-aho, C. Nielsen, J. Ivaska, Y. Taya, S. L. Lu, S. Lin, E. K. Chan, X. J. Wang, R. Grenman, J. Kast, T. Kallunki, R. Sears, V. M. Kahari, and J. Westermarck. 2007. CIP2A inhibits PP2A in human malignancies. Cell 130:51-62.
154. Kang, S., A. G. Bader, and P. K. Vogt. 2005. Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic. Proc. Natl. Acad. Sci. USA 102:802-807.
155. Kaplan, D. R., M. Whitman, B. Schaffhausen, D. C. Pallas, M. White, L. Cantley, and T. M. Roberts. 1987. Common elements in growth factor stimulation and oncogenic transformation: 85 kd phosphoprotein and phosphatidylinositol kinase activity. Cell 50:1021-1029.
156. Kaplan, D. R., M. Whitman, B. Schaffhausen, L. Raptis, R. L. Garcea, D. Pallas, T. M. Roberts, and L. Cantley. 1986. Phosphatidylinositol metabolism and polyoma-mediated transformation. Proc. Natl. Acad. Sci. USA 83:3624-3628.
157. Kelley, W. L., and C. Georgopoulos. 1997. The T/t common exon of simian virus 40, JC, and BK polyomavirus T antigens can functionally replace the J.-domain of the Escherichia coli DnaJ molecular chaperone. Proc. Natl. Acad. Sci. USA 94:3679-3684.
158. Kennedy, A. P., A. Sekulic, B. J. Irvin, A. E. Nilson, S. M. Dilworth, and R. T. Abraham. 1998. Polyomavirus middle T antigen as a probe for T cell antigen receptor-coupled signaling pathways. J. Biol. Chem. 273:11505-11513.
159. Kiefer, F., I. Anhauser, P. Soriano, A. Aguzzi, S. A. Courtneidge, and E. F. Wagner. 1994. Endothelial cell transformation by polyomavirus middle T antigen in mice lacking Src-related kinases. Curr. Biol. 4:100-109.
160. Kim, P. K., F. Janiak-Spens, W. S. Trimble, B. Leber, and D. W. Andrews. 1997. Evidence for multiple mechanisms for membrane binding and integration via carboxyl-terminal insertion sequences. Biochemistry 36:8873-8882.
161. c-src transforming ability by mutation of its primary sites of tyrosine phosphorylation. Cell 49:65-73.
162. Kornbluth, S., F. R. Cross, M. Harbison, and H. Hanafusa. 1986. Transformation of chicken embryo fibroblasts and tumor induction by the middle T antigen of polyomavirus carried in an avian retroviral vector. Mol. Cell. Biol. 6:1545-1551.
163. Kornbluth, S., M. Sudol, and H. Hanafusa. 1987. Association of the polyomavirus middle-T antigen with c-yes protein. Nature 325:171-173. (Pubitemid 17052309)
164. Krauzewicz, N., J. Elliott, and B. E. Griffin. 1994. Cell fractionation in non-ionic detergent distinguishes sub-populations of polyoma virus middle T antigen and reveals a novel form. Oncogene 9:2283-2291. (Pubitemid 24228679)
165. Kurpios, N. A., N. A. Sabolic, T. G. Shepherd, G. M. Fidalgo, and J. A. Hassell. 2003. Function of PEA3 Ets transcription factors in mammary gland development and oncogenesis. J. Mammary Gland Biol. Neoplasia. 8:177-190.
166. Lancaster, M., J. Rouse, and K. W. Hunter. 2005. Modifiers of mammary tumor progression and metastasis on mouse chromosomes 7, 9, and 17. Mamm. Genome 16:120-126.
167. Land, H., L. F. Parada, and R. A. Weinberg. 1983. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 304:596-602.
168. Lei, Q. Y., H. Zhang, B. Zhao, Z. Y. Zha, F. Bai, X. H. Pei, S. Zhao, Y. Xiong, and K. L. Guan. 2008. TAZ promotes cell proliferation and epithelial- mesenchymal transition and is inhibited by the hippo pathway. Mol. Cell. Biol. 28:2426-2436.
169. Le Voyer, T., Z. Lu, J. Babb, T. Lifsted, M. Williams, and K. Hunter. 2000. An epistatic interaction controls the latency of a transgene-induced mammary tumor. Mamm. Genome 11:883-889. (Pubitemid 30745164)
170. Lewis, B. C., D. S. Klimstra, N. D. Socci, S. Xu, J. A. Koutcher, and H. E. Varmus. 2005. The absence of p53 promotes metastasis in a novel somatic mouse model for hepatocellular carcinoma. Mol. Cell. Biol. 25:1228-1237.
171. Lewis, B. C., D. S. Klimstra, and H. E. Varmus. 2003. The c-myc and PyMT oncogenes induce different tumor types in a somatic mouse model for pancreatic cancer. Genes Dev. 17:3127-3138.
172. Li, M., and R. L. Garcea. 1994. Identification of the threonine phosphorylation sites on the polyomavirus major capsid protein VP1: relationship to the activity of middle T antigen. J. Virol. 68:320-327. (Pubitemid 24974635)
173. Lifsted, T., T. Le Voyer, M. Williams, W. Muller, A. Klein-Szanto, K. H. Buetow, and K. W. Hunter. 1998. Identification of inbred mouse strains harboring genetic modifiers of mammary tumor age of onset and metastatic progression. Int. J. Cancer 77:640-644. (Pubitemid 28340915)
174. Lin, E. Y., J. G. Jones, P. Li, L. Zhu, K. D. Whitney, W. J. Muller, and J. W. Pollard. 2003. Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases. Am. J. Pathol. 163:2113-2126.
175. Lin, E. Y., J. F. Li, G. Bricard, W. Wang, Y. Deng, R. Sellers, S. A. Porcelli, and J. W. Pollard. 2007. VEGF restores delayed tumor progression in tumors depleted of macrophages. Mol. Oncol. 1:288-302.
176. Lin, E. Y., A. V. Nguyen, R. G. Russell, and J. W. Pollard. 2001. Colonystimulating factor 1 promotes progression of mammary tumors to malignancy. J. Exp. Med. 193:727-740.
177. Louie, R. R., C. S. King, A. MacAuley, J. D. Marth, R. M. Perlmutter, W. Eckhart, and J. A. Cooper. 1988. p56lck protein-tyrosine kinase is cytoskeletal and does not bind to polyomavirus middle T antigen. J. Virol. 62:4673-4679.
178. Lukacher, A., Y. Ma, J. Carroll, S. Abromson-Leeman, J. Laning, M. Dorf, and T. Benjamin. 1995. Susceptibility to tumors induced by polyoma virus is conferred by an endogenous mouse mammary tumor virus superantigen. J. Exp. Med. 181:1683-1692.
179. Maglione, J. E., E. T. McGoldrick, L. J. Young, R. Namba, J. P. Gregg, L. Liu, D. Moghanaki, L. G. Ellies, A. D. Borowsky, R. D. Cardiff, and C. L. MacLeod. 2004. Polyomavirus middle T-induced mammary intraepithelial neoplasia outgrowths: single origin, divergent evolution, and multiple outcomes. Mol. Cancer Ther. 3:941-953.
180. Maglione, J. E., D. Moghanaki, L. J. Young, C. K. Manner, L. G. Ellies, S. O. Joseph, B. Nicholson, R. D. Cardiff, and C. L. MacLeod. 2001. Transgenic Polyoma middle-T mice model premalignant mammary disease. Cancer Res. 61:8298-8305.
181. Magnusson, G., and P. Berg. 1979. Construction and analysis of viable deletion mutants of polyoma virus. J. Virol. 32:523-529. (Pubitemid 10188767)
182. Magnusson, G., M. Nilsson, S. Dilworth, and N. Smolar. 1981. Characterization of polyoma mutants with altered middle T and large T antigens. J. Virol. 39:673-684. (Pubitemid 11059866)
183. Malmgren, R. A., A. S. Rabson, and P. G. Carney. 1964. Immunity and viral carcinogenesis. effect of thymectomy on polyoma virus carcinogenesis in mice. J. Natl. Cancer Inst. 33:101-104.
184. Man, A. K., L. J. Young, J. A. Tynan, J. Lesperance, M. Egeblad, Z. Werb, C. A. Hauser, W. J. Muller, R. D. Cardiff, and R. G. Oshima. 2003. Ets2-dependent stromal regulation of mouse mammary tumors. Mol. Cell. Biol. 23:8614-8625.
185. Markland, W., C. S. H., B. A. Oostra, and A. E. Smith. 1986. In vitro mutagenesis of the putative membrane-binding domain of polyomavirus middle-T antigen. J. Virol. 59:82-89.
186. Maroulakou, I. G., W. Oemler, S. P. Naber, and P. N. Tsichlis. 2007. Akt1 ablation inhibits, whereas Akt2 ablation accelerates, the development of mammary adenocarcinomas in mouse mammary tumor virus (MMTV)-ErbB2/neu and MMTV-polyoma middle T transgenic mice. Cancer Res. 67:167-177.
187. Martens, I., S. A. Nilsson, S. Linder, and G. Magnusson. 1989. Mutational analysis of polyomavirus small-T-antigen functions in productive infection and in transformation. J. Virol. 63:2126-2133. (Pubitemid 19107809)
188. McKenna, L. B., G. L. Zhou, and J. Field. 2007. Isoform-specific functions of Akt in cell motility. Cell Mol. Life Sci. 64:2723-2725.
189. Meili, R., P. Cron, B. Hemmings, and K. Ballmer-Hofer. 1998. Protein kinase B/Akt is activated by polyomavirus middle-T antigen via a phosphatidylinositol 3-kinase-dependent mechanism. Oncogene 16:903-907. (Pubitemid 28102593)
190. Miller, J. F. 1964. Influence of thymectomy on tumor induction by polyoma virus in C57bl mice. Proc. Soc. Exp. Biol. Med. 116:323-327.
191. Millward, T. A., S. Zolnierowicz, and B. A. Hemmings. 1999. Regulation of protein kinase cascades by protein phosphatase 2A. Trends Biochem. Sci. 24:186-191.
192. Mittag, T., B. Schaffhausen, and U. L. Gunther. 2004. Tracing kinetic intermediates during ligand binding. J. Am. Chem. Soc. 126:9017-9023.
193. Montagna, C., M. S. Lyu, K. Hunter, L. Lukes, W. Lowther, T. Reppert, B. Hissong, Z. Weaver, and T. Ried. 2003. The septin 9 (MSF) gene is ampli- fied and overexpressed in mouse mammary gland adenocarcinomas and human breast cancer cell lines. Cancer Res. 63:2179-2187.
194. Moule, M. G., C. H. Collins, F. McCormick, and M. Fried. 2004. Role for PP2A in ARF signaling to p53. Proc. Natl. Acad. Sci. USA 101:14063-14066.
195. Mueller, C., W. Muller, and J. Hassell. 1988. The polyomavirus enhancer comprises multiple functional elements. J. Virol. 62:1667-1678. (Pubitemid 18133187)
196. Mukherjee, P., C. S. Madsen, A. R. Ginardi, T. L. Tinder, F. Jacobs, J. Parker, B. Agrawal, B. M. Longenecker, and S. J. Gendler. 2003. Mucin 1-specific immunotherapy in a mouse model of spontaneous breast cancer. J. Immunother. 26:47-62. (Pubitemid 36056825)
197. Mullane, K. P., M. Ratnofsky, X. Cullere, and B. Schaffhausen. 1998. Signaling from polyomavirus middle T and small T defines different roles for protein phosphatase 2A. Mol. Cell. Biol. 18:7556-7565.
198. Mumby, M. 2007. PP2A: unveiling a reluctant tumor suppressor. Cell 130:21-24. (Pubitemid 47031327)
199. Munoz, B., and F. F. Bolander, Jr. 1989. Prolactin regulation of mouse mammary tumor virus (MMTV) expression in normal mouse mammary epithelium. Mol. Cell. Endocrinol. 62:23-29.
200. Muraoka, R. S., N. Dumont, C. A. Ritter, T. C. Dugger, D. M. Brantley, J. Chen, E. Easterly, L. R. Roebuck, S. Ryan, P. J. Gotwals, V. Koteliansky, and C. L. Arteaga. 2002. Blockade of TGF-beta inhibits mammary tumor cell viability, migration, and metastases. J. Clin. Invest. 109:1551-1559.
201. Muraoka-Cook, R. S., H. Kurokawa, Y. Koh, J. T. Forbes, L. R. Roebuck, M. H. Barcellos-Hoff, S. E. Moody, L. A. Chodosh, and C. L. Arteaga. 2004. Conditional overexpression of active transforming growth factor β1 in vivo accelerates metastases of transgenic mammary tumors. Cancer Res. 64:9002-9011.
202. Nagle, J. A., Z. Ma, M. A. Byrne, M. F. White, and L. M. Shaw. 2004. Involvement of insulin receptor substrate 2 in mammary tumor metastasis. Mol. Cell. Biol. 24:9726-9735.
203. Namba, R., J. E. Maglione, R. R. Davis, C. A. Baron, S. Liu, C. E. Carmack, L. J. Young, A. D. Borowsky, R. D. Cardiff, and J. P. Gregg. 2006. Heterogeneity of mammary lesions represent molecular differences. BMC Cancer 6:275. (Pubitemid 46178681)
204. Namba, R., J. E. Maglione, L. J. Young, A. D. Borowsky, R. D. Cardiff, C. L. MacLeod, and J. P. Gregg. 2004. Molecular characterization of the transition to malignancy in a genetically engineered mouse-based model of ductal carcinoma in situ. Mol. Cancer Res. 2:453-463.
205. Namba, R., L. J. Young, J. E. Maglione, E. T. McGoldrick, S. Liu, G. T. Wurz, M. W. DeGregorio, A. D. Borowsky, C. L. MacLeod, R. D. Cardiff, and J. P. Gregg. 2005. Selective estrogen receptor modulators inhibit growth and progression of premalignant lesions in a mouse model of ductal carcinoma in situ. Breast Cancer Res. 7:R881-R889.
206. Neznanov, N., A. K. Man, H. Yamamoto, C. A. Hauser, R. D. Cardiff, and R. G. Oshima. 1999. A single targeted Ets2 allele restricts development of mammary tumors in transgenic mice. Cancer Res. 59:4242-4246. (Pubitemid 29418736)
207. Nicholson, P. R., S. Empereur, H. R. Glover, and S. M. Dilworth. 2001. ShcA tyrosine phosphorylation sites can replace ShcA binding in signalling by middle T-antigen. EMBO J. 20:6337-6346.
208. Nielsen, L. L., M. Gurnani, B. Shi, G. Terracina, R. C. Johnson, J. Carroll, J. M. Mathis, and G. Hajian. 2000. Derivation and initial characterization of a mouse mammary tumor cell line carrying the polyomavirus middle T antigen: utility in the development of novel cancer therapeutics. Cancer Res. 60:7066-7074.
209. Niemeyer, C. C., B. Spencer-Dene, J. X. Wu, and E. D. Adamson. 1999. Preneoplastic mammary tumor markers: Cripto and Amphiregulin are overexpressed in hyperplastic stages of tumor progression in transgenic mice. Int. J. Cancer 81:588-591.
210. Nishida, K., and T. Hirano. 2003. The role of Gab family scaffolding adapter proteins in the signal transduction of cytokine and growth factor receptors. Cancer Sci. 94:1029-1033. (Pubitemid 38035515)
211. Novak, U., and B. E. Griffin. 1981. Requirement for the C-terminal region of middle-T antigen in cellular transformation by polyoma virus. Nucleic Acids Res. 9:2055. (Pubitemid 11088201)
212. Ogris, E., D. M. Gibson, and D. C. Pallas. 1997. Protein phosphatase 2A subunit assembly: the catalytic subunit carboxy terminus is important for binding cellular B subunit but not polyomavirus middle tumor antigen. Oncogene 15:911-917. (Pubitemid 27399552)
213. Ogris, E., I. Mudrak, E. Mak, D. Gibson, and D. C. Pallas. 1999. Catalytically inactive protein phosphatase 2A can bind to polyomavirus middle tumor antigen and support complex formation with pp60c-src. J. Virol. 73:7390-7398.
214. Ong, S. H., S. Dilworth, I. Hauck-Schmalenberger, T. Pawson, and F. Kiefer. 2001. ShcA and Grb2 mediate polyoma middle T antigen-induced endothelial transformation and Gab1 tyrosine phosphorylation. EMBO J. 20:6327-6336.
215. Oostra, B., R. Harvey, B. Ely, A. Markham, and A. Smith. 1983. Transforming activity of polyoma virus middle-T antigen probed by site-directed mutagenesis. Nature (London) 304:456-459.
216. O'Shea, C. C., and M. Fried. 2005. Modulation of the ARF-p53 pathway by the small DNA tumor viruses. Cell Cycle 4:449-452.
217. Pallas, D. C., H. Fu, L. C. Haehnel, W. Weller, R. J. Collier, and T. M. Roberts. 1994. Association of polyomavirus middle tumor antigen with 14-3-3 proteins. Science 265:535-537.
218. Pallas, D. C., W. Morgan, and T. M. Roberts. 1989. The cellular proteins which can associate specifically with polyomavirus middle T antigen in human 293 cells include the major human 70-kilodalton heat shock proteins. J. Virol. 63:4533-4539.
219. Pallas, D. C., L. K. Shahrik, B. L. Martin, S. Jaspers, T. B. Miller, D. L. Brautigan, and T. M. Roberts. 1990. Polyoma small and middle T antigens and SV40 small t antigen form stable complexes with protein phosphatase 2A. Cell 60:167-176. (Pubitemid 20033919)
220. Pankratz, S. L., E. Y. Tan, Y. Fine, A. M. Mercurio, and L. M. Shaw. 2008. Insulin receptor substrate-2 regulates aerobic glycolysis in mouse mammary tumor cells via glucose transporter 1. J. Biol. Chem. 284:2031-2037.
221. Park, Y. G., R. Clifford, K. H. Buetow, and K. W. Hunter. 2003. Multiple cross and inbred strain haplotype mapping of complex-trait candidate genes. Genome Res. 13:118-121.
222. Park, Y. G., X. Zhao, F. Lesueur, D. R. Lowy, M. Lancaster, P. Pharoah, X. Qian, and K. W. Hunter. 2005. Sipa1 is a candidate for underlying the metastasis efficiency modifier locus Mtes1. Nat. Genet. 37:1055-1062.
223. Pedersen, T. X., C. J. Pennington, K. Almholt, I. J. Christensen, B. S. Nielsen, D. R. Edwards, J. Romer, K. Dano, and M. Johnsen. 2005. Extracellular protease mRNAs are predominantly expressed in the stromal areas of microdissected mouse breast carcinomas. Carcinogenesis 26:1233-1240.
224. Pelicci, G., L. Lanfrancone, F. Grignani, J. McGlade, F. Cavallo, G. Forni, I. Nicoletti, F. Grignani, T. Pawson, and P. G. Pelicci. 1992. A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction. Cell 70:93-104.
225. Perou, C. M., T. Sorlie, M. B. Eisen, M. van de Rijn, S. S. Jeffrey, C. A. Rees, J. R. Pollack, D. T. Ross, H. Johnsen, L. A. Akslen, O. Fluge, A. Pergamenschikov, C. Williams, S. X. Zhu, P. E. Lonning, A. L. Borresen- Dale, P. O. Brown, and D. Botstein. 2000. Molecular portraits of human breast tumours. Nature 406:747-752.
226. Piwnica-Worms, H., D. R. Kaplan, M. Whitman, and T. M. Roberts. 1986. Retrovirus shuttle vector for study of kinase activities of pp60c-src synthesized in vitro and overproduced in vivo. Mol. Cell. Biol. 6:2033-2040.
227. Piwnica-Worms, H., K. B. Saunders, T. M. Roberts, A. E. Smith, and S. H. Cheng. 1987. Tyrosine phosphorylation regulates the biochemical properties of pp60c-src. Cell 49:75-82.
228. Podsypanina, K., Y. C. Du, M. Jechlinger, L. J. Beverly, D. Hambardzumyan, and H. Varmus. 2008. Seeding and propagation of untransformed mouse mammary cells in the lung. Science 321:1841-1844.
229. Primo, L., C. Roca, C. Ferrandi, L. Lanfrancone, and F. Bussolino. 2000. Human endothelial cells expressing polyoma middle T induce tumors. Oncogene 19:3632-3641. (Pubitemid 30608484)
230. Putzer, B. M., J. L. Bramson, C. L. Addison, M. Hitt, P. M. Siegel, W. J. Muller, and F. L. Graham. 1998. Combination therapy with interleukin-2 and wild-type p53 expressed by adenoviral vectors potentiates tumor regression in a murine model of breast cancer. Hum. Gene Ther. 9:707-718.
231. Qin, L., L. Liao, A. Redmond, L. Young, Y. Yuan, H. Chen, B. W. O'Malley, and J. Xu. 2008. The AIB1 oncogene promotes breast cancer metastasis by activation of PEA3-mediated matrix metalloproteinase 2 (MMP2) and MMP9 expression. Mol. Cell. Biol. 28:5937-5950.
232. Qiu, T. H., G. V. Chandramouli, K. W. Hunter, N. W. Alkharouf, J. E. Green, and E. T. Liu. 2004. Global expression profiling identifies signatures of tumor virulence in MMTV-PyMT-transgenic mice: correlation to human disease. Cancer Res. 64:5973-5981.
233. Raptis, L., H. Lamfrom, and T. L. Benjamin. 1985. Regulation of cellular phenotype and expression of polyoma virus middle T antigen in rat fibroblasts. Mol. Cell. Biol. 5:2476-2485.
234. Rassoulzadegan, M., S. A. Courtneidge, R. Loubiere, P. el Baze and F. Cuzin. 1990. A variety of tumours induced by the middle T antigen of polyoma virus in a transgenic mouse family. Oncogene 5:1507-1510.
235. Rauh, M. J., V. Blackmore, E. R. Andrechek, C. G. Tortorice, R. Daly, V. K. Lai, T. Pawson, R. D. Cardiff, P. M. Siegel, and W. J. Muller. 1999. Accelerated mammary tumor development in mutant polyomavirus middle T transgenic mice expressing elevated levels of either the Shc or Grb2 adapter protein. Mol. Cell. Biol. 19:8169-8179.
236. Ravichandran, K. S. 2001. Signaling via Shc family adapter proteins. Oncogene 20:6322-6330.
237. Richard, S., G. Vogel, M. E. Huot, T. Guo, W. J. Muller, and K. E. Lukong. 2008. Sam68 haploinsufficiency delays onset of mammary tumorigenesis and metastasis. Oncogene 27:548-556.
238. Riley, M. I., W. Yoo, N. Y. Mda, and W. R. Folk. 1997. Tiny T antigen: an autonomous polyomavirus T antigen amino-terminal domain. J. Virol. 71: 6068-6074.
239. Ritland, S. R., G. J. Rowse, Y. Chang, and S. J. Gendler. 1997. Loss of heterozygosity analysis in primary mammary tumors and lung metastases of MMTV-MTAg and MMTV-neu transgenic mice. Cancer Res. 57:3520-3525.
240. Rondinelli, R. H., S. Z. Haslam, and M. M. Fluck. 1995. The role of ovarian hormones, age and mammary gland development in polyomavirus mammary tumorigenesis. Oncogene 11:1817-1827.
241. Rose, P., and Schaffhausen. 1995. Zinc-binding and protein-protein interaction mediated by the polyomavirus large T zinc finger. J. Virol. 69:2842-2849.
242. Rowe, W. P. 1961. The epidemiology of mouse polyoma virus infection. Bacteriol. Rev. 25:18-31.
243. Ruediger, R., H. T. Pham, and G. Walter. 2001. Alterations in protein phosphatase 2A subunit interaction in human carcinomas of the lung and colon with mutations in the A beta subunit gene. Oncogene 20:1892-1899. (Pubitemid 32458699)
244. Ruley, H. E. 1983. Adenovirus early region 1A enables viral and cellular transforming genes to transform primary cells in culture. Nature 304:602-606.
245. Sablina, A. A., W. Chen, J. D. Arroyo, L. Corral, M. Hector, S. E. Bulmer, J. A. DeCaprio, and W. C. Hahn. 2007. The tumor suppressor PP2A Aβ regulates the RalA GTPase. Cell 129:969-982. (Pubitemid 46813152)
246. Salcini, A. E., J. McGlade, G. Pelicci, I. Nicoletti, T. Pawson, and P. Peilicci. 1994. Formation of Shc-Grb2 complexes is necessary to induce neoplastic transformation by overexpression of Shc proteins. Oncogene 9:2827-2836.
247. Reference deleted.
248. Samuels, Y., L. A. Diaz, Jr., O. Schmidt-Kittler, J. M. Cummins, L. Delong, I. Cheong, C. Rago, D. L. Huso, C. Lengauer, K. W. Kinzler, B. Vogelstein, and V. E. Velculescu. 2005. Mutant PIK3CA promotes cell growth and invasion of human cancer cells. Cancer Cell 7:561-573. (Pubitemid 40799249)
249. Samuels, Y., and V. E. Velculescu. 2004. Oncogenic mutations of PIK3CA in human cancers. Cell Cycle 3:1221-1224. (Pubitemid 40268595)
250. Sausville, J., A. A. Molinolo, X. Cheng, J. Frampton, N. Takebe, J. S. Gutkind, and R. A. Feldman. 2008. RCAS/SCL-TVA animal model allows targeted delivery of polyoma middle T oncogene to vascular endothelial progenitors in vivo and results in hemangioma development. Clin. Cancer Res. 14:3948-3955.
251. Schaffhausen, B. 1982. Transforming genes and gene products of polyoma and SV40. CRC Crit. Rev. Biochem. 13:215-286.
252. Schaffhausen, B. S., and T. Benjamin. 1981. Two polyoma middle T antigen species differing in in vivo phosphorylation and in vitro kinase activity. J. Virol. 40:184.
253. Schaffhausen, B. S., and T. L. Benjamin. 1979. Phosphorylation of polyoma T antigens. Cell 18:935-946.
254. Schaffhausen, B. S., and T. L. Benjamin. 1981. Polyoma virus middle T antigen associated protein kinase, p. 1281-1300. In O. M. Rosen and E. G. Krebs (ed.), Protein phosphorylation, vol.8. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
255. Schaffhausen, B. S., B. J. Bockus, K. L. Berkner, D. Kaplan, and T. M. Roberts. 1987. Characterization of middle T antigen expressed by using an adenovirus expression system. J. Virol. 61:1221-1225. (Pubitemid 17044037)
256. Schaffhausen, B. S., H. Dorai, G. Arakere, and T. L. Benjamin. 1982. Polyoma virus middle T antigen: relationship to cell membranes and apparent lack of ATP-binding activity. Mol. Cell. Biol. 2:1187-1198.
257. Schaffhausen, B. S., T. J. Liang, G. G. Carmichael, and T. L. Benjamin. 1985. Residual transforming activity of PY1178T, a mutant lacking the principal in vitro phosphorylation site is not affected by removal of the secondary tyrosine phosphorylation site at residue 322. Virology 143:671-675.
258. Schaffhausen, B. S., and T. M. Roberts. 2009. Lessons from polyoma middle T antigen on signaling and transformation: a DNA tumor virus contribution to the war on cancer. Virology 384:304-316.
259. Scheidtmann, K. H., M. C. Mumby, K. Rundell, and G. Walter. 1991. Dephosphorylation of simian virus 40 large-T antigen and p53 protein by protein phosphatase 2A: inhibition by small-t antigen. Mol. Cell. Biol. 11:1996-2003.
260. Schlessinger, J., and M. A. Lemmon. 2003. SH2 and PTB domains in tyrosine kinase signaling. Sci. STKE 2003:RE12.
261. Schoeffner, D. J., S. L. Matheny, T. Akahane, V. Factor, A. Berry, G. Merlino, and U. P. Thorgeirsson. 2005. VEGF contributes to mammary tumor growth in transgenic mice through paracrine and autocrine mechanisms. Lab. Invest. 85:608-623.
262. Schonthal, A., S. Srinivas, and W. Eckhart. 1992. Induction of c-jun protooncogene expression and transcription factor AP-1 activity by the polyoma virus middle-sized tumor antigen. Proc. Natl. Acad. Sci. USA. 89: 4972-4976.
263. Sefton, B. M., T. Hunter, K. Beemon, and W. Eckhart. 1980. Evidence that the phosphorylation of tyrosine is essential for cellular transformation by Rous sarcoma virus. Cell 20:807-816. (Pubitemid 10078560)
264. Senften, M., S. Dilworth, and K. Ballmer-Hofer. 1997. Multimerization of polyomavirus middle-T antigen. J. Virol. 71:6990-6995.
265. Sheng, Q., D. Denis, M. Ratnofsky, T. Roberts, J. DeCaprio, and B. Schaffhausen. 1997. The DnaJ domain of polyoma Large T is required to regulate Rb family tumor tuppressor function. J. Virol. 71.:9410-9416. (Pubitemid 27492384)
266. Shepard, C. R., J. Kassis, D. L. Whaley, H. G. Kim, and A. Wells. 2007. PLC gamma contributes to metastasis of in situ-occurring mammary and prostate tumors. Oncogene 26:3020-3026.
267. Shepherd, T., and J. A. Hassell. 2001. Role of Ets transcription factors in mammary gland development and oncogenesis. J. Mammary Gland Biol. Neoplasia 6:129-140. (Pubitemid 33640651)
268. Siegler, R., and T. L. Benjamin. 1975. Oncogenicity of wild-type and nontransforming mutants of polyoma virus. Proc. Am. Assoc. Cancer Res. 16:99.
269. Silver, J., B. Schaffhausen, and T. Benjamin. 1978. Tumor antigens induced by nontransforming mutants of polyoma virus. Cell 15:485-496. (Pubitemid 9052418)
270. Siwko, S. K., W. Bu, C. Gutierrez, B. Lewis, M. Jechlinger, B. Schaffhausen, and Y. Li. 2008. Lentivirus-mediated oncogene introduction into mammary cells in vivo induces tumors. Neoplasia 10:653-662.
271. Sjoegren, H. O. 1964. Studies on specific transplantation resistance to polyoma-virus-induced tumors. IV. Stability of the polyoma cell antigen. J. Natl. Cancer Inst. 32:661-666.
272. Skolnik, E. Y., B. Margolis, M. Mohammadi, E. Lowenstein, R. Fischer, A. Drepps, A. Ullrich, and J. Schlessinger. 1991. Cloning of PI3 kinase-associated p85 utilizing a novel method for expression/cloning of target proteins for receptor tyrosine kinases. Cell 65:83-90.
273. Smith, A. E., R. Smith, B. Griffin, and M. Fried. 1979. Protein kinase activity associated with polyoma virus middle T antigen in vitro. Cell 18: 915-924.
274. Soeda, E., J. R. Arrand, N. Smolar, and B. E. Griffin. 1979. Sequence from early region of polyoma virus DNA containing viral replication origin and encoding small, middle and (part of) large T antigens. Cell 17:357-370. (Pubitemid 9230316)
275. Songyang, Z., S. Shoelson, M. Chauduri, G. Gish, T. Pawson, W. Haser, F. King, T. Roberts, S. Ratnofsky, R. Lechleider, B. Neel, R. Birge, J. Fajardo, M. Chou, H. Hanafusa, B. Schaffhausen, and L. Cantley. 1993. SH2 domains recognize specific phosphopeptide sequences. Cell 72:767-778. (Pubitemid 23093884)
276. Sorlie, T., R. Tibshirani, J. Parker, T. Hastie, J. S. Marron, A. Nobel, S. Deng, H. Johnsen, R. Pesich, S. Geisler, J. Demeter, C. M. Perou, P. E. Lonning, P. O. Brown, A. L. Borresen-Dale, and D. Botstein. 2003. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc. Natl. Acad. Sci. USA 100:8418-8423.
277. Srinivas, S., A. Schonthal, and W. Eckhart. 1994. Polyoma virus middlesized tumor antigen modulates c-jun phosphorylation and transcriptional activity. Proc. Natl. Acad. Sci. USA 91:10064-10068.
278. Srinivasan, A., A. J. McClellan, J. Vartikar, I. Marks, P. Cantalupo, Y. Li, P. Whyte, K. Rundell, J. L. Brodsky, and J. M. Pipas. 1997. The aminoterminal transforming region of simian virus 40 large T and small t antigens functions as a J. domain. Mol. Cell. Biol. 17:4761-4773.
279. Stewart, S. E., B. E. Eddy, A. M. Gochenour, G. Borgese, and G. E. Grubbs. 1957. The induction of neoplasms with a substance released from mouse tumors by tissue culture. Virol. 3:380-400.
280. Stringer, J. R., J. S. Larson, J. M. Fischer, M. Medvedovic, M. N. Hersh, G. P. Boivin, and S. L. Stringer. 2005. Modeling variation in tumors in vivo. Proc. Natl. Acad. Sci. USA 102:2408-2413.
281. Stubdal, H., J. Zalvide, K. S. Campbell, C. Schweitzer, T. M. Roberts, and J. A. DeCaprio. 1997. Inactivation of pRB-related proteins p130 and p107 mediated by the J. domain of simian virus 40 large T antigen. Mol. Cell. Biol. 17:4979-4990.
282. Su, W., W. Liu, B. Schaffhausen, and T. Roberts. 1995. Association of polyomavirus middle tumor antigen with phospholipase C-gamma 1. J. Biol. Chem. 270:12331-12335.
283. Sullivan, C. S., and J. M. Pipas. 2002. T antigens of simian virus 40: molecular chaperones for viral replication and tumorigenesis. Microbiol. Mol. Biol. Rev. 66:179-202.
284. Summers, S. A., L. Lipfert, and M. J. Birnbaum. 1998. Polyoma middle T antigen activates the Ser/Thr kinase Akt in a PI3-kinase-dependent manner. Biochem. Biophys. Res. Commun. 246:76-81.
285. Szabova, L., S. S. Yamada, H. Birkedal-Hansen, and K. Holmbeck. 2005. Expression pattern of four membrane-type matrix metalloproteinases in the normal and diseased mouse mammary gland. J. Cell Physiol. 205:123-132. (Pubitemid 41262858)
286. Tehranian, A., D. W. Morris, B. H. Min, D. J. Bird, R. D. Cardiff, and P. A. Barry. 1996. Neoplastic transformation of prostatic and urogenital epithelium by the polyoma virus middle T gene. Am. J. Pathol. 149:1177-1191.
287. Templeton, D., and W. Eckhart. 1984. Characterization of viable mutants of polyomavirus cold sensitive for maintenance of cell transformation. J. Virol. 49:799-805. (Pubitemid 14191141)
288. Templeton, D., and W. Eckhart. 1982. Mutation causing premature termination of the polyoma virus middle T antigen blocks cell transformation. J. Virol. 41:1014-1024. (Pubitemid 12180230)
289. Templeton, D., and W. Eckhart. 1984. N-terminal amino acid sequences of the polyoma middle-size T antigen are important for protein kinase activity and cell transformation. Mol. Cell. Biol. 4:817-821.
290. Templeton, D., S. Simon, and W. Eckhart. 1986. Truncated forms of the polyomavirus middle T antigen can substitute for the small T antigen in lytic infection. J. Virol. 57:367-370. (Pubitemid 16147956)
291. Templeton, D., A. Voronova, and W. Eckhart. 1984. Construction and expression of a recombinant DNA gene encoding a polyoma middle-size tumor antigen with the carboxyl terminus of the VSV glycoprotein G. Mol. Cell. Biol. 4:282-289.
292. Thomas, J. E., A. Aguzzi, P. Soriano, E. F. Wagner, and J. S. Brugge. 1993. Induction of tumor formation and cell transformation by polyoma middle T antigen in the absence of Src. Oncogene 8:2521-2529. (Pubitemid 23252382)
293. Tian, Y., R. Kolb, J. H. Hong, J. Carroll, D. Li, J. You, R. Bronson, M. B. Yaffe, J. Zhou, and T. Benjamin. 2007. TAZ promotes PC2 degradation through a SCFβ-Trcp E3 ligase complex. Mol. Cell. Biol. 27:6383-6395.
294. Tian, Y., D. Li, J. Dahl, J. You, and T. Benjamin. 2004. Identification of TAZ as a binding partner of the polyomavirus T antigens. J. Virol. 78: 12657-12664. (Pubitemid 39458783)
295. Tower, G. B., C. I. Coon, and C. E. Brinckerhoff. 2003. The 2G single nucleotide polymorphism (SNP) in the MMP-1 promoter contributes to high levels of MMP-1 transcription in MCF-7/ADR breast cancer cells. Breast Cancer Res. Treatment 82:75-82.
296. Treisman, R., A. Cowie, J. Favaloro, P. Jat, and R. Kamen. 1981. The structures of spliced mRNAs encoding polyoma virus early region proteins. J. Mol. Appl. Gen. 1:83-92.
297. Treisman, R., U. Novak, J. Favaloro, and R. Kamen. 1981. Transformation of rat cells by an altered polyoma virus genome expressing only the middle T protein. Nature 292:595-600. (Pubitemid 11023997)
298. Trimble, M. S., J. H. Xin, C. T. Guy, W. J. Muller, and J. A. Hassell. 1993. PEA3 is overexpressed in mouse metastatic mammary adenocarcinomas. Oncogene 8:3037-3042. (Pubitemid 23312908)
299. Tyndall, C., G. La Mantia, C. M. Thacker, J. Favaloro, and R. Kamen. 1981. A region of the polyoma virus genome between the replication origin and late protein coding sequences is required in cis for both early gene expression and viral DNA replication. Nucleic Acids Res. 9:6231-6250.
300. Ulug, E. T., P. T. Hawkins, M. R. Hanley, and S. A. Courtneidge. 1990. Phosphatidylinositol metabolism in cells transformed by polyomavirus middle T antigen. J. Virol. 64:3895-3904. (Pubitemid 20227214)
301. Urich, M., M. Y. el Shemerly, D. Besser, Y. Nagamine, and K. Ballmer- Hofer. 1995. Activation and nuclear translocation of mitogen-activated protein kinases by polyomavirus middle-T or serum depend on phosphatidylinositol 3-kinase. J. Biol. Chem. 270:29286-29292.
302. Urich, M., M. Senften, P. E. Shaw, and K. Ballmer-Hofer. 1997. A role for the small GTPase Rac in polyomavirus middle-T antigen-mediated activation of the serum response element and in cell transformation. Oncogene 14:1235-1241. (Pubitemid 27141927)
303. Utermark, T., B. S. Schaffhausen, T. M. Roberts, and J. J. Zhao. 2007. The p110alpha isoform of phosphatidylinositol 3-kinase is essential for polyomavirus middle T antigen-mediated transformation. J. Virol. 81:7069-7076. (Pubitemid 46986643)
304. van der Geer, P., S. Wiley, G. D. Gish, V. K. Lai, R. Stephens, M. F. White, D. Kaplan, and T. Pawson. 1996. Identification of residues that control specific binding of the Shc phosphotyrosine-binding domain to phosphotyrosine sites. Proc. Natl. Acad. Sci. USA 93:963-968.
305. Vandeputte, M., H. Eyssen, H. Sobis, and P. de Somer. 1974. Induction of polyoma tumors in athymic nude mice. Int. J. Cancer 14:445-450.
306. van der Geer, P., S. Wiley, G. D. Gish, and T. Pawson. 1996. The Shc adaptor protein is highly phosphorylated at conserved, twin tyrosine residues (Y239/240) that mediate protein-protein interactions. Curr. Biol. 6:1435-1444.
307. van der Geer, P., S. Wiley, V. K. Lai, J. P. Olivier, G. D. Gish, R. Stephens, D. Kaplan, S. Shoelson, and T. Pawson. 1995. A conserved amino-terminal Shc domain binds to phosphotyrosine motifs in activated receptors and phosphopeptides. Curr. Biol. 5:404-412.
308. Vanhaesebroeck, B., and M. D. Waterfield. 1999. Signaling by distinct classes of phosphoinositide 3-kinases. Exp. Cell Res. 253:239-254.
309. Varticovski, L., B. Druker, D. Morrison, L. Cantley, and T. Roberts. 1989. The colony stimulating factor-1 receptor associates with and activates phosphatidylinositol- 3 kinase. Nature 342:699-702. (Pubitemid 20001589)
310. Vasiljeva, O., M. Korovin, M. Gajda, H. Brodoefel, L. Bojic, A. Kruger, U. Schurigt, L. Sevenich, B. Turk, C. Peters, and T. Reinheckel. 2008. Reduced tumour cell proliferation and delayed development of high-grade mammary carcinomas in cathepsin B-deficient mice. Oncogene 27:4191-4199. (Pubitemid 351969911)
311. Vasiljeva, O., A. Papazoglou, A. Kruger, H. Brodoefel, M. Korovin, J. Deussing, N. Augustin, B. S. Nielsen, K. Almholt, M. Bogyo, C. Peters, and T. Reinheckel. 2006. Tumor cell-derived and macrophage-derived cathepsin B promotes progression and lung metastasis of mammary cancer. Cancer Res. 66:5242-5250. (Pubitemid 43844948)
312. Veldman, G., S. Lupton, and R. Kamen. 1985. Polyomavirus enhancer contains multiple redundant sequence elements that activate both DNA replication and gene expression. Mol. Cell. Biol. 5:649-658.
313. Ventura, A., L. Luzi, S. Pacini, C. T. Baldari, and P. G. Pelicci. 2002. The p66Shc longevity gene is silenced through epigenetic modifications of an alternative promoter. J. Biol. Chem. 277:22370-22376.
314. Versteeg, H. H., F. Schaffner, M. Kerver, L. G. Ellies, P. Andrade-Gordon, B. M. Mueller, and W. Ruf. 2008. Protease-activated receptor (PAR) 2, but not PAR1, signaling promotes the development of mammary adenocarcinoma in polyoma middle T mice. Cancer Res. 68:7219-7227.
315. Vomachka, A. J., S. L. Pratt, J. A. Lockefeer, and N. D. Horseman. 2000. Prolactin gene-disruption arrests mammary gland development and retards T-antigen-induced tumor growth. Oncogene 19:1077-1084.
316. Walter, G., A. Carbone, and W. J. Welch. 1987. Medium tumor antigen of polyomavirus transformation-defective mutant NG59 is associated with 73- kilodalton heat shock protein. J. Virol. 61:405-410. (Pubitemid 17001738)
317. Walter, G., R. Ruediger, C. Slaughter, and M. Mumby. 1990. Association of protein phosphatase 2A with polyoma virus medium tumor antigen. Proc. Natl. Acad. Sci. USA 87:2521-2525.
318. Wang, S., Y. Yuan, L. Liao, S. Q. Kuang, J. C. Tien, B. W. O'Malley, and J. Xu. 2009. Disruption of the SRC-1 gene in mice suppresses breast cancer metastasis without affecting primary tumor formation. Proc. Natl. Acad. Sci. USA 106:151-156.
319. Wang, S. S., E. D. Esplin, J. L. Li, L. Huang, A. Gazdar, J. Minna, and G. A. Evans. 1998. Alterations of the PPP2R1B gene in human lung and colon cancer. Science 282:284-287. (Pubitemid 28487198)
320. Wang, W., J. B. Wyckoff, S. Goswami, Y. Wang, M. Sidani, J. E. Segall, and J. S. Condeelis. 2007. Coordinated regulation of pathways for enhanced cell motility and chemotaxis is conserved in rat and mouse mammary tumors. Cancer Res. 67:3505-3511. (Pubitemid 46762128)
321. Wasylyk, C., P. Flores, A. Gutman, and B. Wasylyk. 1989. PEA3 is a nuclear target for transcription activation by non-nuclear oncogenes. EMBO J. 8:3371-3378. (Pubitemid 19273566)
322. Webster, M., J. Hutchinson, M. Rauh, S. Muthuswamy, M. Anton, C. Tortorice, R. Cardiff, F. Graham, J. Hassell, and W. Muller. 1998. Requirement for both Shc and phosphatidylinositol 3 kinase signaling pathways in polyomavirus middle T-mediated mammary tumorigenesis. Mol. Cell. Biol. 18:2344-2359.
323. Welm, A. L., J. B. Sneddon, C. Taylor, D. S. Nuyten, M. J. van de Vijver, B. H. Hasegawa, and J. M. Bishop. 2007. The macrophage-stimulating protein pathway promotes metastasis in a mouse model for breast cancer and predicts poor prognosis in humans. Proc. Natl. Acad. Sci. USA 104:7570-7575.
324. Westermarck, J., and W. C. Hahn. 2008. Multiple pathways regulated by the tumor suppressor PP2A in transformation. Trends Mol. Med. 14:152-160.
325. Whalen, K. A., R. de Jesus, J. A. Kean, and B. S. Schaffhausen. 2005. Genetic analysis of the polyomavirus DnaJ domain. J. Virol. 79:9982-9990.
326. Whalen, K. A., G. F. Weber, T. L. Benjamin, and B. S. Schaffhausen. 2008. Polyomavirus middle T antigen induces the transcription of osteopontin, a gene important for the migration of transformed cells. J. Virol. 82:4946-4954.
327. White, D. E., N. A. Kurpios, D. Zuo, J. A. Hassell, S. Blaess, U. Mueller, and W. J. Muller. 2004. Targeted disruption of β1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction. Cancer Cell 6:159-170.
328. Whitman, M., C. P. Downes, M. Keeler, T. Keller, and L. Cantley. 1988. Type I phosphatidylinositol kinase makes a novel inositol phospholipid, phosphatidylinositol-3-phosphate. Nature 332:644-646. (Pubitemid 18110256)
329. Whitman, M., D. Kaplan, T. Roberts, and L. Cantley. 1987. Evidence for two distinct phosphatidylinositol kinases in fibroblasts. Biochem. J. 247:165-174.
330. Whitman, M., D. R. Kaplan, B. Schaffhausen, L. Cantley, and T. M. Roberts. 1985. Association of phosphatidylinositol kinase activity with polyoma middle-T competent for transformation. Nature 315:239-242. (Pubitemid 15064453)
331. Williams, R. L., S. A. Courtneidge, and E. F. Wagner. 1988. Embryonic lethalities and endothelial tumors in chimeric mice expressing polyoma virus middle T oncogene. Cell 52:121-131. (Pubitemid 18054594)
332. Williams, R. L., W. Risau, H. G. Zerwes, H. Drexler, A. Aguzzi, and E. F. Wagner. 1989. Endothelioma cells expressing the polyoma middle T oncogene induce hemangiomas by host cell recruitment. Cell 57:1053-1063.
333. Winter, S. F., and K. W. Hunter. 2008. Mouse modifier genes in mammary tumorigenesis and metastasis. J. Mammary Gland Biol. Neoplasia 13:337-342.
334. Wirth, J. J., A. Amalfitano, R. Gross, M. B. Oldstone, and M. M. Fluck. 1992. Organ- and age-specific replication of polyomavirus in mice. J. Virol. 66:3278-3286.
335. Wyckoff, J., W. Wang, E. Y. Lin, Y. Wang, F. Pixley, E. R. Stanley, T. Graf, J. W. Pollard, J. Segall, and J. Condeelis. 2004. A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res. 64:7022-7029. (Pubitemid 39331012)
336. Wyckoff, J. B., Y. Wang, E. Y. Lin, J. F. Li, S. Goswami, E. R. Stanley, J. E. Segall, J. W. Pollard, and J. Condeelis. 2007. Direct visualization of macrophage- assisted tumor cell intravasation in mammary tumors. Cancer Res. 67:2649-2656.
337. Yang, C. S., M. J. Vitto, S. A. Busby, B. A. Garcia, C. T. Kesler, D. Gioeli, J. Shabanowitz, D. F. Hunt, K. Rundell, D. L. Brautigan, and B. M. Paschal. 2005. Simian virus 40 small t antigen mediates conformationdependent transfer of protein phosphatase 2A onto the androgen receptor. Mol. Cell. Biol. 25:1298-1308.
338. Yang, L., J. Huang, X. Ren, A. E. Gorska, A. Chytil, M. Aakre, D. P. Carbone, L. M. Matrisian, A. Richmond, P. C. Lin, and H. L. Moses. 2008. Abrogation of TGF beta signaling in mammary carcinomas recruits Gr- 1+CD11b+ myeloid cells that promote metastasis. Cancer Cell 13:23-35. (Pubitemid 350309741)
339. Yang, S. I., R. L. Lickteig, R. Estes, K. Rundell, G. Walter, and M. C. Mumby. 1991. Control of protein phosphatase 2A by simian virus 40 small-t antigen. Mol. Cell. Biol. 11:1988-1995.
340. Yen, A., V. Cherington, B. Schaffhausen, K. Marks, and S. Varvayanis. 1999. Transformation-defective polyoma middle T antigen mutants defective in PLCγ, PI-3, or src kinase activation enhance ERK2 activation and promote retinoic acid-induced, cell differentiation like wild-type middle T. Exp. Cell Res. 248:538-551.
341. Yi, X., and R. Freund. 1998. Deletion of proline-rich domain in polyomavirus T antigens results in virus partially defective in transformation and tumorigenesis. Virology 248:420-431. (Pubitemid 28417727)
342. Yi, X., J. Peterson, and R. Freund. 1997. Transformation and tumorigenic properties of a mutant polyoma virus containing a middle T antigen defective in shc binding. J. Virol. 71:6279-6286. (Pubitemid 27355280)
343. Yoakim, M., W. Hou, Y. Liu, C. L. Carpenter, R. Kapeller, and B. S. Schaffhausen. 1992. Interactions of polyomavirus middle T with the SH2 domains of the pp85 subunit of phosphatidylinositol-3-kinase. J. Virol. 66:5485-5491.
344. Yonemoto, W., A. J. Filson, A. E. Queral-Lustig, J. Y. Wang, and J. S. Brugge. 1987. Detection of phosphotyrosine-containing proteins in polyomavirus middle tumor antigen-transformed cells after treatment with a phosphotyrosine phosphatase inhibitor. Mol. Cell. Biol. 7:905-913.
345. Yonemoto, W., M. Jarvis-Morar, J. S. Brugge, J. B. Bolen, and M. A. Israel. 1985. Tyrosine phosphorylation within the amino-terminal domain of pp60c-src molecules associated with polyoma virus middle-sized tumor antigen. Proc. Natl. Acad. Sci. USA 82:4568-4572.
346. Zhao, J. J., H. Cheng, S. Jia, L. Wang, O. V. Gjoerup, A. Mikami, and T. M. Roberts. 2006. The p110α isoform of PI3K is essential for proper growth factor signaling and oncogenic transformation. Proc. Natl. Acad. Sci. USA 103:16296-16300.
347. Zhao, J. J., Z. Liu, L. Wang, E. Shin, M. F. Loda, and T. M. Roberts. 2005. The oncogenic properties of mutant p110α and p110β phosphatidylinositol 3-kinases in human mammary epithelial cells. Proc. Natl. Acad. Sci. USA 102:18443-18448.
348. Zhou, J., H. T. Pham, R. Ruediger, and G. Walter. 2003. Characterization of the Aα and Aβ subunit isoforms of protein phosphatase 2A: differences in expression, subunit interaction, and evolution. Biochem. J. 369:387-398. (Pubitemid 36174209)
349. Zhu, W., A. Eicher, B. Leber, and D. W. Andrews. 1998. At the onset of transformation polyomavirus middle-T recruits shc and src to a perinuclear compartment coincident with condensation of endosomes. Oncogene 17:565-576. (Pubitemid 28401025)
350. Zhu, Z. Y., G. M. Veldman, A. Cowie, A. Carr, B. Schaffhausen, and K. R. 1984. Construction and functional characterization of polyomavirus genomes that separately encode the three early proteins. J. Virol. 51:170.